Physician profile
Danielle Bennett
NPI 1881717528
$618.63
in general payments reported to CMS, 2019-2025
11 companies · $36.39 in 2025
The $36.39 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.41 · 2020: $138 · 2022: $330 · 2024: $93.51 · 2025: $36.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $129.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $117.51 | 2020-2022 | |
| Abbvie INC. | $115.00 | 2022 | |
| Cochlear Americas | $93.51 | 2024 | Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha |
| Lilly USA, LLC | $83.98 | 2020-2022 | |
| Glaxosmithkline, LLC. | $63.87 | 2022 | |
| Baxter Healthcare | $36.39 | 2025 | Perclot |
| Sanofi-Aventis U.S. LLC | $30.06 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $27.86 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $20.41 | 2019 | |
| Medtronic USA, INC. | $15.86 | 2020 | |
| Merck Sharp & Dohme LLC | $14.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.